IonQ to Advance Hybrid Quantum Computing with New Chemistry Application and NVIDIA CUDA-Q
IonQ uses the NVIDIA CUDA-Q platform alongside IonQ Forte to demonstrate an end-to-end application workflowThe work reaffirms IonQ’s focus on making quantum acceleration as simple and ubiquitous as GPU acceleration for on-prem and hybrid deployments
IonQ (NYSE: IONQ), a leader in the quantum computing and networking industry, announced today the completion of an industry-first demonstration of an end-to-end application workflow that leverages the NVIDIA CUDA-Q platform alongside IonQ’s leading quantum computing hardware.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241118387486/en/

IonQ to Advance Hybrid Quantum Computing with New Chemistry Application and NVIDIA CUDA-Q (Graphic: Business Wire)
Showcased via a joint presentation at SC24, the application demonstrates the seamless integration of the core workflow behind several hybrid quantum-classical approaches to calculate the specific properties of a molecule’s electronic structure. These approaches have potential relevance in many chemistry-focused commercial applications, such as identifying how drug molecules might interact with specific proteins in the human body. The achievement captures IonQ’s interest in developing solutions that combine the benefits of quantum processing units (QPUs) with the accelerated, heterogeneous computing capabilities of the NVIDIA CUDA-Q platform.
“IonQ is building on its approach of accelerating AI, scientific compute, and other supercomputing workloads with quantum hardware – enabling entirely new ways to approach previously unsolvable problems,” said Dean Kassmann, SVP of Engineering & Technology at IonQ. “Today’s molecular modeling demonstration illustrates why CUDA-Q is a great platform for achieving seamless integration and top-tier performance with our leading quantum hardware.”
Since 2023, IonQ has supported NVIDIA CUDA-Q, a powerful, unified, open-source software stack. CUDA-Q is a hybrid quantum-classical computing platform that enables the integration and programming of QPUs and GPUs in a single workflow. This demonstration was performed using a combination of IonQ Forte, the IonQ Hybrid Services suite, CUDA-Q, and NVIDIA A100 Tensor Core GPUs, which can be deployed to cloud and on-prem environments.
The demonstration at SC24 showcases a novel way to interrogate the properties of specific molecules in a resource-efficient way that has relevance in larger application workflows pertaining to pharma and other commercial domains. The work also sets the stage for IonQ to accelerate even more powerful ways to model molecular dynamics for future biopharmaceutical applications.
“Useful quantum applications will need to draw on both quantum hardware and AI supercomputing resources,” said Elica Kyoseva, Director of Quantum Algorithm Engineering, NVIDIA. “The CUDA-Q platform is allowing researchers and developers to explore these paradigms by accessing NVIDIA accelerated computing alongside IonQ’s quantum processors.”
Today’s news reaffirms IonQ’s commitment to developing hardware and software that leverages a combination of quantum and classical computation to enable efficient, performant, robust solutions that can be deployed at commercial scale.
IonQ’s Hybrid Services suite makes designing and deploying quantum-accelerated applications that take advantage of IonQ’s leading quantum hardware easier than ever. It achieves this via a flexible, easy-to-configure hybrid infrastructure, workflow management, and scheduling for cloud or on-prem installations. Further, it has powerful tools to help application developers explore new applications and use cases, such as prebuilt solvers for problem classes like quadratic optimization and graph partitioning, and out-of-the-box support for a variety of common programming models, including NVIDIA CUDA-Q quantum kernels.
To learn more about IonQ and its latest system news and business developments, visit https://ionq.com/.
About IonQ
IonQ, Inc. is a leader in quantum computing that delivers high-performance systems capable of solving the world’s largest and most complex commercial and research use cases. IonQ’s current generation quantum computer, IonQ Forte, is the latest in a line of cutting-edge systems, boasting 36 algorithmic qubits. The company’s innovative technology and rapid growth were recognized in Fast Company’s 2023 Next Big Things in Tech List and Deloitte’s 2023 Technology Fast 500™ List, respectively. Available through all major cloud providers, IonQ is making quantum computing more accessible and impactful than ever before. Learn more at IonQ.com.
IonQ Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “accelerate,” “accelerated,” “acceleration,” “achieving,” “developing,” “enables,” “enabling,” “explore,” “leverages,” “might,” “potential,” “will,” and other similar expressions are intended to identify forward-looking statements. These statements include those related to the company’s technology driving commercial quantum advantage in the future, the ability for third parties to implement IonQ’s offerings to increase their quantum computing capabilities, the potential commercial relevance of described chemistry-focused applications, whether IonQ’s offerings can or will continue to be integrated with third party systems, the potential benefits of integrating quantum processing units with third party offerings, IonQ’s quantum computing capabilities and plans, access to IonQ’s quantum computers, increases in performance, and the scalability, efficiency, and durability of IonQ’s quantum computing offerings. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: market adoption of quantum computing solutions and IonQ’s products, services and solutions; changes in the competitive industries in which IonQ operates, including development of competing technologies; changes in laws and regulations affecting IonQ’s business; IonQ’s ability to implement its business plans, forecasts and other expectations, and identify and realize partnerships and opportunities. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the Company’s filings, including but not limited to those described in the “Risk Factors” section of IonQ’s most recent Quarterly Report on Form 10-Q and other documents filed by IonQ from time to time with the Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. IonQ does not give any assurance that it will achieve its expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118387486/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fujirebio Receives Marketing Clearance for Lumipulse®G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease17.5.2025 08:58:00 CEST | Press release
—First Blood-Based In-Vitro Diagnostic Test to Receive FDA Clearancefor Patients Being Assessed for Alzheimer’s Disease. ——Availability of Accurate, Accessible, Blood-Based Diagnostic Tests Will Aid in Development and Availability of More Effective Interventions for Alzheimer’s Disease — Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s Lumipulse® G pTau 217/β-Amyloid 1-42 Plasma Ratio in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. The test, which was granted Breakthrough Device Designation by the FDA, is the first FDA cleared blood-based IVD test in the U.S. to aid to identify patients with amyloid pathology associated with Alzheimer’s Disease (AD). Alzheimer’s disease currently affects an estimated 7.2 million Americans, a number projected to rise to nearly 14 million by 2060.1 It is a leading cause
IFF Announces Pricing of Tender Offers For Certain Outstanding Series of Notes16.5.2025 23:17:00 CEST | Press release
IFF (NYSE: IFF) announced today the Total Consideration (as defined below) payable in connection with its previously announced tender offers to purchase for cash: (i) up to $1,100,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 1 Maximum Amount”), of its 1.230% Senior Notes due 2025 (the “2025 Notes”), 1.832% Senior Notes due 2027 (the “2027 Notes”), 4.450% Senior Notes due 2028 (the “2028 Notes”) and 2.300% Senior Notes due 2030 (the “2030 Notes” and collectively with the 2025 Notes, the 2027 Notes and the 2028 Notes, the “Pool 1 Notes”) and (ii) up to $900,000,000 aggregate purchase price, excluding accrued and unpaid interest (the “Amended Pool 2 Maximum Amount” and, together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), of its 3.268% Senior Notes due 2040 (the “2040 Notes”), 4.375% Senior Notes due 2047 (the “2047 Notes”), 5.000% Senior Notes due 2048 (the “2048 Notes”) and 3.468% Senior Notes due 2050 (the “2050
Origins Launches in the U.S. Amazon Premium Beauty Store16.5.2025 15:00:00 CEST | Press release
The brand brings its high-performance, clinically proven, nature-inspired skincare to Amazon shoppers Origins, with over 30 years of expertise in combining naturally-derived and scientifically crafted ingredients for powerful skincare, announced its official debut in the U.S. Amazon Premium Beauty store today. Origins will offer its iconic skincare and body care products along with giftable sets that are perfect for any occasion. Origins will now bring naturally-derived, effective beauty to Amazon customers nationwide with convenience and thoughtful gifting in mind. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250516435958/en/ This launch marks a strategic step in Origins’ ongoing efforts to meet the evolving needs of skincare shoppers, seeking high-performance, conscious beauty on their favorite platforms. By expanding to the U.S. Amazon Premium Beauty store, Origins reinforces its commitment to delivering both efficacy a
The smarter E Europe 2025: Studies, Technologies and Market Trends for the Energy System of Tomorrow16.5.2025 12:47:00 CEST | Press release
Exactly one week has passed since The smarter E Europe closed its doors in Munich. Once again, Europe’s largest alliance of exhibitions for the energy industry turned the Bavarian capital into the epicenter of the global energy sector and impressed with outstanding results. Over the course of three days, 2,737 exhibitors from 57 countries showcased their technologies, business models and market-ready solutions for an intelligent, interconnected and fully renewable energy system. Around 107,000 professionals from 157 nations took the opportunity to connect, initiate partnerships and launch new projects. The accompanying conferences and side events also attracted strong interest, drawing more than 2,600 participants. The message sent out by The smarter E Europe and its four exhibitions – Intersolar Europe, ees Europe, Power2Drive Europe and EM-Power Europe – was clear: We are the energy system. This press release features multimedia. View the full release here: https://www.businesswire.c
IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes16.5.2025 12:30:00 CEST | Press release
IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Pool 1 Maximum Amount, the “Amended Maximum Amounts”), the 2027 Series Tender Cap (as defined below) from $300,000,000 to $400,000,000 and the 2050 Series Tender Cap (as defined below) from $600,000,000 to $649,114,000. The 2025 Notes Series Tender Cap and the 2040 Notes Series Tender Cap (each as defined below) remain unchanged at $500,000,000 and $450,000,000, respectively. Details of tender offers IFF initially offered to purchase for cash: (i) up to $1,000,000,000 aggregate purchase price, excluding accrued and unpaid in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom